Postmenopause Health Priorities: What to Monitor and What to Ask

Postmenopause begins the day you have gone twelve months without a period, and lasts for the rest of your life. Some symptoms settle in this phase, but genital and urinary changes progress without treatment, and bone and cardiovascular risk quietly rise. The focus shifts from riding out fluctuation to protecting long-term health.

What postmenopause means

Once the twelve month mark passes, hormone levels stop swinging and settle at a consistently low level. For many people that stability is a relief in itself, particularly for mood symptoms driven by fluctuation.

It does not mean symptoms end. It means the pattern changes, and the health priorities change with it.

What tends to settle, and what does not

That right hand column is the part most often endured unnecessarily. Genitourinary symptoms respond well to treatment and rarely resolve on their own, so waiting achieves nothing. See our long-term health section.

Hot flashes can outlast the transition

A common assumption is that flashes stop once periods have. For a significant proportion of people they continue for years into postmenopause, and for some they persist much longer.

If yours are still disrupting sleep or work, that is a reason to seek treatment rather than evidence that you are unusual. Effective hormonal and non-hormonal options exist regardless of how long it has been since your final period, though the discussion around starting hormone therapy differs once you are more than ten years past menopause or over sixty.

Any bleeding needs assessment

This is the single most important point in postmenopausal care. Once twelve months have passed with no bleeding, any bleeding needs prompt medical assessment: light spotting, a single episode, brown discharge, or bleeding after sex.

Most causes are benign, often thinning of the vaginal or womb lining. But it is the principal symptom of endometrial cancer, which is very treatable when caught early. Do not wait to see whether it happens again.

Bone

Loss was fastest around the final period and continues more slowly afterwards. Because osteoporosis is symptomless until a fracture, this is managed by assessment rather than by how you feel.

• Progressive resistance training and weight bearing activity, not walking alone
• Adequate calcium and vitamin D
• Balance work, because most fractures follow a fall
• Assessment where risk factors exist, including early menopause, steroid use, a parental hip fracture, smoking or a previous fracture from a minor fall

A fracture from a fall at standing height after around age fifty should always be mentioned to a clinician rather than treated as bad luck.

Heart and circulation

Cardiovascular disease is the leading cause of death in women, and several risk markers shift unfavourably across the transition. In postmenopause the useful approach is measurement rather than reassurance.

Ask for your blood pressure reading, a full lipid profile, and a blood sugar check, and ask what your calculated ten year risk actually is. Mention your menopause age and any pregnancy complications such as pre-eclampsia or gestational diabetes, since both affect risk assessment and are often missing from midlife records.

Keep screening going

Menopause does not replace or pause routine screening, and uptake often falls in this age group.

• Cervical screening, as invited, until you age out of the programme
• Breast screening, as invited
• Bowel screening, as invited
• Blood pressure and cardiovascular checks
• Eye and dental checks, which are easy to let lapse

Muscle and strength

Muscle mass declines with age, and the decline accelerates without loading. This matters for more than appearance: muscle is the main site of glucose disposal, it protects bone, and it determines whether you can get up from the floor unaided in later decades.

Resistance training at least twice a week, covering the major muscle groups and progressing over time, alongside adequate protein spread across the day, is the most effective intervention available in this phase.

Cognition

Word finding difficulty and lapses in concentration are common during the transition and typically stabilise afterwards. Persistent, progressive memory problems are different and should be assessed rather than attributed to menopause. If daily familiar tasks are affected, or others notice more than you do, raise it.

Review your medicines

Postmenopause is a sensible point for a medication review. Some medicines affect bone density, some affect bladder function, some raise falls risk through dizziness or blood pressure drops, and some interact with treatments started for menopausal symptoms. Ask for a review rather than assuming everything on the list is still needed at the same dose.

What to ask at your appointment

• Should I be assessed for fracture risk, and has it been calculated?
• What are my blood pressure, lipids and blood sugar results?
• What is my ten year cardiovascular risk?
• Could vaginal estrogen help my genital or urinary symptoms?
• Am I up to date with cervical, breast and bowel screening?
• If I take hormone therapy, when should it be reviewed, and on what basis?
• Do any of my medicines affect bone, bladder or falls risk?

When to seek medical advice

• Any bleeding at all, including spotting, which needs prompt assessment
• A fracture from a minor fall, height loss, or new curvature of the upper back
• Persistent pelvic pain, bloating, or unexplained weight loss
• Recurrent urinary infections
• Persistent vulval itching, a lump, an ulcer or a patch of changed skin
• Progressive memory problems affecting daily tasks
• Chest pain, breathlessness or palpitations, which need urgent assessment

FAQs

How long does postmenopause last?

The rest of your life. It is a permanent stage rather than a phase you pass through.

Why am I still getting hot flashes years later?

Because they commonly outlast the final period, sometimes by many years. Persisting flashes are a reason to seek treatment, not a sign that something is wrong with you.

Is it too late to start HRT?

Not necessarily, but the discussion changes once you are more than ten years past menopause or over sixty, and the balance of benefit and risk is weighed differently. Vaginal estrogen for genital and urinary symptoms is a separate question with a different profile.

I had one episode of spotting. Should I worry?

You should have it assessed promptly, which is not the same as worrying. Most causes are benign, but a single episode is enough to warrant checking.

Do I still need vaginal estrogen forever?

Symptoms generally return when it stops, so it is usually continued long term. That is expected rather than a sign of dependence.

Will my bones definitely become osteoporotic?

No. Bone loss continues but the outcome depends on your starting density, your risk factors and what you do. Loading the skeleton, adequate nutrition and falls prevention all meaningfully change the trajectory.

Do I need contraception now?

Not once you are genuinely postmenopausal by the twelve month definition. If hormonal contraception has masked your cycles, confirm your position with a clinician rather than assuming.

Is weight gain inevitable now?

No, though the drivers change. Ageing and muscle loss matter more than hormones, and resistance training with adequate protein addresses the underlying cause more effectively than restriction.

Bottom line

Postmenopause is a permanent stage in which the volatility of the transition ends but the health picture keeps moving. Mood and bleeding usually settle, hot flashes may persist for years, and genital and urinary symptoms progress without treatment. The useful shift is towards measurement and prevention: bone assessment, cardiovascular numbers, continued screening, resistance training and protein. And one rule admits no exceptions, which is that any bleeding needs prompt assessment.

References

1. National Institute for Health and Care Excellence. Menopause: identification and management (NG23). Published 12 November 2015, last updated 15 April 2026. nice.org.uk
2. National Institute for Health and Care Excellence. Osteoporosis: risk assessment (NG259). Published 29 July 2026. Updates and replaces CG146. nice.org.uk
3. National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238). Published December 2023. Updates and replaces CG181. nice.org.uk

Sources verified 10 September 2026. Clinical guidance is updated periodically, and availability of specific treatments differs by country, so check current national guidance. This article is general information and does not replace individual medical advice.